AGWCA
ASTH icon

Annis Gardner Whiting Capital Advisors’s Astrana Health ASTH Stock Holding History

Annis Gardner Whiting Capital Advisors’s Portfolio ASTH Stock Details ASTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-19
Closed -$466 – 1296
2026
Q1 		$466 Sell
19
-3
-14% -$71 ﹤0.01% 1214
2025
Q4 		$546 Buy
+22
New +$584 ﹤0.01% 1104

Other funds holding ASTH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
3C
325 Capital New York $419M AUM 75.74% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Annis Gardner Whiting Capital Advisors's ASTH Position: Q2 2026 in Review

Annis Gardner Whiting Capital Advisors sold out of Astrana Health (ASTH) in Q2 2026, closing a stake of 19 shares — an estimated $466 sold.

Annis Gardner Whiting Capital Advisors first reported a position in ASTH in Q4 2025 and held it in 2 quarters. The position peaked at $546 in Q4 2025. 210 funds tracked by Wall St. Rank hold ASTH as of Q2 2026.

  • Annis Gardner Whiting Capital Advisors reported no remaining Astrana Health position as of Q2 2026 after selling out during the quarter.
  • Annis Gardner Whiting Capital Advisors sold 19 Astrana Health shares in Q2 2026, an estimated $466.
  • Annis Gardner Whiting Capital Advisors first reported a position in Astrana Health in Q4 2025 and held it in 2 quarters.
  • Annis Gardner Whiting Capital Advisors's Astrana Health position peaked at $546 in Q4 2025.
  • 210 funds tracked by Wall St. Rank held Astrana Health as of Q2 2026.

Based on Annis Gardner Whiting Capital Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.